190 likes | 363 Vues
Presenter Disclosure Information Harvey L. Levy, MD. The following relationships exists related to this presentation: No relationship to disclose. Methionine Metabolic Cycle. MethionineTHF SAM5-MTHF SAH5, 10-MTHFHomocysteineCystathionineCystei
E N D
1. The Homocystinurias Harvey L. Levy, MD
Childrens Hospital Boston
Harvard Medical School
2. Presenter Disclosure InformationHarvey L. Levy, MD The following relationships exists related to this presentation:
No relationship to disclose
3. Methionine Metabolic Cycle Methionine
THF
SAM
5-MTHF SAH
5, 10-MTHF
Homocysteine
Cystathionine
Cysteine
4. Methionine Metabolic CycleGene/Enzyme of Transporter MAT I/III Methionine adenosyltransferase I/III
GNMT N-Glycine methyltransferase
AHH Adenosylhomcysteine hydrolase
CBS Cystathionine B-synthase
MTHFR Methylenetetrahydrofolate reductase
MMACHC Methylmalonic aciduria homocystinuria C (cblC
MMADHC Methylmalonic aciduria homocystinuric D (cblD)
LMBRDI cbl F transporter
MSRR Methionine synthase reductase (cblE)
MSR Methionine synthase (cblG)
5. HOMOCYSTINURIA (cbs def) Mental retardation
Ectopia lentis
Skeletal abnormalities
Thromboembolism
6. NBS ELEVATED METHIONINE
7. Homocystinuria B6 Challenge
B6-responsive or B6-nonresponsive?
Administer B6 (pyridoxine) 250 mg PO daily X3 days when on normal diet
Measure plasma methionine and homocysteine daily
Marked reduction indicates B6-responsive
Do not give infant more than 250 mg pyridoxine
8. Homocystinuria Therapy
Methionine-restricted diet
Methionine-free formula
Low-protein foods (medical)
B6 (?), B12 (?), folic acid (?)
Betaine
9. Homocystinuria Goal of Therapy
Metabolic
Reduce homocystine/homocysteine
(optimal level(s) not yet known)
Clinical
Normality
(monitor eyes, development/IQ, bone density)
10. MAT I/III Deficiency Biochemical
Increased methionine
Reduced S-adenosylmethionine (SAM)
Normal/slightly increase homocysteine
Clinical
Benign
?Mild developmental delay
*Contact Dr. Harvey Mudd at NIH for analysis
Tel: 301-496-0681
Email: shm@codon.nih.gov
11. N-Glycine methyltransferase (GNMT) deficiency Biochemical
Increased methionine
Increased S-adenosylmethionine (SAM)
Normal/slightly increased homocysteine
Clinical
Liver disease
*Contact Dr. Harvey Mudd for analysis
12. Adenosylhomocysteine hydrolase (AHH) deficiency Biochemical
Increased methionine
Increased S-adenosylmethionine (SAM)
Normal/slightly increased homocysteine
Clinical
Myopathy
Hypertonia
Developmental Delay
*Contact Dr. Harvey Mudd for analysis
13. Methylenetetrahydrofolate reductase (MTHFR) deficiency Biochemical
Decreased methionine
Increased homocysteine
No methylmalonic aciduria
Clinical
Developmental delay/MR
Subacute combined degeneration of the spinal cord (SCD) with hypotonia and peripheral neuropathy
14. NBS Elevated C3
15. Cobalamin C (clbc) DefectB12 Metabolic Defect(Methylmalonic aciduria/Homocystinuria)
16. CblC DisorderClinical
Newborn usually normal
Developmental delay/MR
Poor vision/blindness (retinal degeneration)
Seizures
Megaloblastic anemia
17. CblC DisorderTreatment
Normal diet
Vitamin B12 (OHCbl) at least 1 mg IM daily
Betaine ~ 200-250 mg/kg/day
?Carnitine ~ 50-100 mg/kg/day
?Supplemental methionine
18. cblD disorder Biochemical
Decreased methionine
Methylmalonic aciduria only
or
Homocystinuria only
or
Both methylmalonic aciduria and homocystinuria
Clinical
Developmental delay/MR
Seizures
(eyes are normal)
19. cblF disorder Biochemical
Decreased methionine
Methylmalonic aciduria (possibly increased homocysteine)
Clinical
Developmental delay
20. cblE and cblG disorders Biochemical
Decreased methionine
Markedly increased homocysteine
Methylmalonic acid absent
Clinical
Developmental delay
Megaloblastic anemia